We are highlighting 2 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non‐depressed adults: a retrospective … [Read more...]
New Publications from the TI PharmacoEpidemiology Group
We are highlighting 4 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study Comparison of cholinesterase … [Read more...]
Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research
Carney, G, Maclure, M, Bassett, K, Taylor, S, Dormuth, CR Pharmacoepidemiol Drug Saf. 2019; 1– 9. https://doi.org/10.1002/pds.4926 Abstract Purpose To describe and implement a novel method of measuring comparative effectiveness using sequential episodes of pharmacotherapy as a proxy for treatment failure. Methods Retrospective cohort study using linked deidentified data from the British … [Read more...]
Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer’s medications in British Columbia
Fisher A, Carney G, Bassett K, Maclure KM, Dormuth CR … [Read more...]
Influence of opioid prescribing standards on drug use among patients with long-term opioid use: a longitudinal cohort study
Morrow RL, Bassett K, Wright JM, Carney G, Dormuth CR … [Read more...]
Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study
Morrow RL, Bassett K, Maclure M, Dormuth CR … [Read more...]
Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
Morrow RL, Dormuth CR, Paterson M, Mamdani MM, Gomes T, Juurlink DN; Canadian Drug Safety Effectiveness Research Network (CDSERN) … [Read more...]
